Drug ID: | NPD196 |
Drug Name: | BAY-86-9596 |
Molecular Formula: | C10H12FNO3 |
Canonical SMILES: | [18F]COc1ccc(cc1)C[C@H](C(=O)O)N |
Standard InCHI: | InChI=1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1 |
Standard InCHIKey: | GEBHVOHKNWLITQ-DEVVULMSSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB006461 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 213.08 |
ALogP | -0.9972 |
MLogP | 2.01 |
XLogP | -0.788 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 8 |
TPSA | 72.55 |
RO5 Violation | 0 |